chrisvoncsefalvay/vaers-outcomes huggingface dataset:
had her 2nd booster last Aug 2021/had covid back on Sep; had her 2nd booster last Aug 2021/had covid back on Sep; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 78-year-old female patient received BNT162b2 (BNT162B2), in Aug2021 as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant) all with onset Sep2022, outcome "unknown" and all described as "had her 2nd booster last Aug 2021/had covid back on Sep".  Clinical Course: It was reported that, In call said she is scheduled for her 3rd booster dose of the Pfizer covid vaccine at 4'oclock today but had covid back on Sep, so she is asking if she needs to wait 6 or 3 months after her recent infection before getting the 3rd booster. Caller says she had her 2nd booster last Aug2021 and that she is 78 years old.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
SITE WAS LEFT ARM INTRAMUSCULAR INJECTION-REACTION WAS SWELLING, REDNESS BAND ALONG SITE, THROBBING.
Woke up with red spots and it progressed to a very large area on upper left arm,with warmth and redness,pain. Starting taking Benadryl and applied ice , hydrocortisone cream. Lasted Sat,Sun, Mon,Tues.
FELT LITTLE SICK; HEADACHE IN ONE SIDE OF HEAD; This spontaneous report received from a patient concerned a 67 year old female.  The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient experienced drug allergy when treated with sulfamethoxazole/trimethoprim. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1821287, expiry: 30-OCT-2021) dose was not reported, administered on 19-JUL-2021 for prophylactic vaccination. No concomitant medications were reported. On 13-DEC-2021, the patient experienced felt little sick, and headache in one side of head. On 16-DEC-2021, Laboratory data included: Antibody test (NR: not provided) 57.9, has antibodies, and SARS-CoV-2 rapid diagnostic test (NR: not provided) negative. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the headache in one side of head and felt little sick was not reported. This report was non-serious.
Per vaccinator,  while administering vaccine she pushed the dose and after the plunger reached the end of the syringe (full dose given) the needle broke off of the syringe at the hub. Vaccinator gently removed needle and hub from patient's arm. A replacement dose was not needed or administered as the patient received the full dose.  Syringe and needle was brand named.
States woke up morning after receiving flu shot with very stiff and painful back, feeling achy and stiff all over, but especially back and spinal cord area. Didn't take temp but feels feverish with sweating and chills. Took OTC fever/pain reducer. States felt achy for about 4 days in bed for most and of that period. Spoke to patient again on 11/17/08. States feels good now except same lower back stiffness and pain. occasionally.
Low grade fever for 48 hours, 2.5x5 cm hard raised area around injection site, could not raise left arm 36 hours.
Two days following injection I was quite dizzy and very sluggish. This lasted for a good week. To this day I am very tired. Injection site was very red for two weeks.  My body continues to feel ?heavy?. My dizziness comes and goes.
Same day post vax, the pt developed urticaria which worsened through the night prompting office visit the following morning. Exam showed urticaria, significant, but otherwise normal. Treated with Atarax.
Patient reported severe right arm pain that started the day after her vaccine was given. She was encouraged to take ibuprofen as needed and reassured that the pain typically resolved in 72 hours. Nearly completely resolved by 3/20/18.
DOSE #1      After about an hour, my face was flushed and arm sore, of course.      Later 1st day and for next 5 days, EXTREMELY fatigued and tired; VERY hard to concentrate. Sinuses felt a bit congested during this time. Also had difficulty staying asleep first 3 nights after injection. Tiredness and fatigue took approx. 2 1/2 weeks to resolve completely.      After 2nd day I began to experience joint pain and swelling, including elbow and knee. I do not normally have any problems with this. I could barely bend my knee. These symptoms lasted over a week. During this time I also had episodes of mild dizziness and nausea, but nothing that hindered my daily activities.        Redness at injection site, which at one point was 4 - 5 inches in diameter, lasted approx. 2 1/2 weeks before it completely disappeared.  DOSE #2 (03/30/2021)       No problem sleeping after 2nd dose.      Much more pain/redness at injection site.      Again, experiencing extreme fatigue, feeling exhausted, difficulty concentrating.  This time joint pain/swelling is minor.      With the 2nd dose, I also am experiencing swollen lymph nodes (left side, underarm), and a odd taste in my mouth 24/7.      I expect this too will resolve after a few weeks.   In addition to the allergies listed on page one, I do have many other allergies and sensitivities (too many to list on this form). I cannot have wine due to sulfites, processed meat due to nitrites and nitrates, I stay away from most processed food, am allergic to cats and dogs, and have severe reactions to wasp/bee/bug stings and/or bites.  Last year I was stung by a wasp on my ear and hand. The complications of extreme swelling, pain, dizziness, nausea, swollen lymph nodes in my neck/throat area, took more than a month to resolve.  I can not eat or drink anything with artificial sweetener. The list goes on...  So, I am not surprised I reacted like I did to the vaccine. However, I was grateful to have this vaccine and feel fortunate to have had the opportunity.          Thank you and have a wonderful day!
approx 5min p/vax pt returned to nurse c/o itching;hives noted to pt body;tx w/epi & decadron & DPH, pt left clinic p/approx 1hr of monitoring;
I had itching swelling, heat, and redness at the injection site the day after my shot. The itching, warmth, and swelling went down after a couple days, but almost two weeks later I still have discoloration. It?s not as red as it was, but kind of red violet. Like a rosy bruise. I read that it?s supposed to go away after a couple days, but it?s been a while, so I thought I would report it. It?s not affecting me in any way at the moment.
Aching - tired loss of appetite for 36 hrs. Mini flu reaction. Treatment - TYLENOL sleeping unable to function.
Got tetanus injection 2/20/03 behind triceps; now c/o pain and swelling.
prescription of the / vaccine to a 42 year old male patient; This case was reported by a pharmacist via call center representative and described the occurrence of intercepted product prescribing error in a 42-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced intercepted product prescribing error. On an unknown date, the outcome of the intercepted product prescribing error was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The healthcare professional reported that the Shingrix was prescribed to the 42 years old patient and planned to be given, which led to intercepted product prescribing error. The reporter did not consent or not decline to follow up. No further events were reported.
temp 103/temp 99.9; severe headache; severe fatigue; muscle soreness; yellow nasal secretions; yellow and bloody sputum; yellow and bloody sputum; This is a spontaneous report from a contactable nurse. A 59-year-old female patient (not pregnant) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL1284, expiry date unknown), intramuscular (right arm) on 12Jan2021 15:45, at single dose, for covid-19 immunization. The patient had no medical history and had no known allergies. There were no concomitant medications. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EH9899), on 21Dec2020 14:00 for covid-19 immunization, vaccine location left arm, at 59 years old. After 18 hours of obtaining shot, on 13Jan2021 09:00 the patient experienced temp 103, severe headache, severe fatigue, muscle soreness, yellow nasal secretions, yellow and bloody sputum. Now on day 4 after shot, 16Jan2021, the patient still had temp 99.9, headache, fatigue, nasal secretions and, sputum secretions less. No treatment was received for the adverse events reported. The patient was recovering from the events. The patient had no other vaccine in four weeks, had no other medications in two weeks, had no Covid prior vaccination, and had not been Covid-tested post-vaccination.
kind of lost the appetite; seemed weakened; A spontaneous report was received from a Healthcare Professional concerning a 93-years-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events kind of lost the appetite, seemed weakened.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 15 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot batch: 013L20A) for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the events kind of lost the appetite . On an unknown date, the patient experienced the events seemed weakened.  Treatment details included Extra hydrocort tablet.  Action taken with mRNA-1273 in response to the events was not reported.   On an unknown date the outcome of events include, kind of lost the appetite, seemed weakened was not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
I woke up the morning after 2/4/2021 with a fever 100.3 at 7:30am, 100.9 at 10am, I took two Tylenol at 10am. 100.3 at 1:15pm, 100.7 at 2:30pm, I took two more Tylenol at 2:30pm.  101.1 at 3:30pm, 101.2 at 5:30pm, 100.8 at 6:30pm, I took two Tylenol at 6:30pm,  100.9 at 10:30pm  I took two Tylenol at 10:30pm,  Friday morning I took two Tylenol at 6:30am, 99.6 at 7:30am, 99.1 at 9am, 98.9 at 10am, 100.8 at 2pm, 99.1 at 6:00pm, 98.1 at 8pm
flu like symptoms; had fever; had chills; Joint and muscle pain in his left arm, shoulder, hand, and neck; Joint and muscle pain in his left arm, shoulder, hand, and neck; This spontaneous case was reported by an other caregiver and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms), PYREXIA (had fever), CHILLS (had chills), MYALGIA (Joint and muscle pain in his left arm, shoulder, hand, and neck) and ARTHRALGIA (Joint and muscle pain in his left arm, shoulder, hand, and neck) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038A21A and 006M20A) for COVID-19 vaccination.     The patient's past medical history included COPD and Post-traumatic stress disorder. Concomitant products included LORATADINE, FLUTICASONE, OXYBUTYNIN, BUDESONIDE, SALBUTAMOL (ALBUTEROL HFA), VITAMIN B12 NOS, VITAMIN D3, OMEPRAZOLE, METFORMIN, DOCUSATE, MULTIVITAMIN [VITAMINS NOS], FISH OIL (OMEGA-3 FISH OIL), TRAMADOL, FLUOXETINE, BUSPIRONE, SERTRALINE, BUPROPION, PREGABALIN (LYRICA), ZIPRASIDONE, MAGNESIUM OXIDE and FERROUS SULFATE (IRON SULFATE) for an unknown indication.   On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms), PYREXIA (had fever), CHILLS (had chills), MYALGIA (Joint and muscle pain in his left arm, shoulder, hand, and neck) and ARTHRALGIA (Joint and muscle pain in his left arm, shoulder, hand, and neck). The patient was treated with PARACETAMOL at a dose of 1 dosage form. On 22-Feb-2021, INFLUENZA LIKE ILLNESS (flu like symptoms), PYREXIA (had fever) and CHILLS (had chills) had resolved. At the time of the report, MYALGIA (Joint and muscle pain in his left arm, shoulder, hand, and neck) and ARTHRALGIA (Joint and muscle pain in his left arm, shoulder, hand, and neck) outcome was unknown. Not Provided          Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-089129 (Patient Link).   Reporter did not allow further contact
Moderna given to 17 year old patient, dose two to complete series based on CDC recommendation.  Patient was initially given Moderna as a 17 year old patient on 3/23/2021
I ADMINISTERED PATIENT'S SECOND DOSE OF PEDIATRIC PFIZER AND WHEN I WENT TO WRITE IN THE LOT NUMBER AND EXPIRATION DATE FOR THE VACCINE AND DILUENT, I REALIZED THE DILUENT WAS EXPIRED BY 11 DAYS (EXPIRED 2/1/22).
Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021; Vaccine received post its 30 days Expiry date; This spontaneous case was reported by an emergency medical technician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine received post its 30 days Expiry date) and PRODUCT STORAGE ERROR (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021) in a 38-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Feb-2022 at 4:34 PM, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) .5 milliliter. On 19-Feb-2022 at 4:34 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine received post its 30 days Expiry date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine received post its 30 days Expiry date) and PRODUCT STORAGE ERROR (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication of the patient was not reported.  Vaccine administration time was given as 19 Feb 2022 at 16:34:31.  No treatment information was provided by the reporter.   This case was linked to MOD-2022-542869 (Patient Link).
Developed sore throat, cough, mild fever (101º),headache beginning on 8/30/22
Severe shoulder pain and limited range of motion.  Trouble sleeping.  Pain eminates.  Have been taking ibuprofen and resting shoulder, yet pain continues a week later.
This spontaneous report as received from a consumer refers to his wife of unknown age. On unspecified date, the patient was vaccinated with PNEUMOVAX 23 (dose, route and lot not reported). No concomitant medications were reported. The consumer reported that on unspecified date, his wife was vaccinated with PNEUMOVAX 23 and he believed that he and his wife received PNEUMOVAX 23 twice. At the time of the report the patient's outcome was unknown. This is one of several reports from the same source. Additional information is not expected.
tested positive for COVID (swab); lack of efficacy; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (tested positive for COVID (swab)) and DRUG INEFFECTIVE (lack of efficacy) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 088O21A, 014M20A and 012M20A) for COVID-19 vaccination.     The patient's past medical history included Prostate cancer (10 years ago) in 2011, Kidney stones and Gallbladder stones. Concurrent medical conditions included Hypertension, Blood cholesterol abnormal, Asthma, Acid reflux (oesophageal), Stomach ache and Allergy. Concomitant products included PANTOPRAZOLE for Acid reflux (oesophageal), LEVOCETIRIZINE for Allergy, FLUTICASONE PROPIONATE;SALMETEROL for Asthma, VENLAFAXINE for Stomach pain, LOSARTAN, CHLORTHALIDONE and POTASSIUM CITRATE for an unknown indication.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Nov-2021, the patient experienced COVID-19 (tested positive for COVID (swab)) and DRUG INEFFECTIVE (lack of efficacy). At the time of the report, COVID-19 (tested positive for COVID (swab)) and DRUG INEFFECTIVE (lack of efficacy) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Nov-2021, SARS-CoV-2 test: positive (Positive) positive. On an unknown date, SARS-CoV-2 test: negative (Negative) negative, tested via self test a few days back.         No treatment drugs were reported.  The patient was not immunocompromised.  It was reported that patient did not have any adverse reaction to any of the doses of the vaccines.  COVID symptoms started 3 days ago and included dry cough, lightheadedness (previous day), low level like sinus headache, funny taste in mouth, stomach discomfort, and nausea. The physician had recommended the patient to take the booster dose and the patient took it.   Most recent FOLLOW-UP information incorporated above includes: On 10-Nov-2021: Follow up document received on 10-NOV-2021 contains no new information. On 13-Nov-2021: Follow up document received on 15-NOV-2021 includes no new information. On 16-Nov-2021: Follow-up received on 16-Nov-2021: Added missed information : current conditions added.; Sender's Comments: This is a spontaneous case concerning a 72-year-old male patient with no relevant medical history, who experienced non serious, AESI, unexpected event of COVID 19; lack of efficacy was considered as an additional event. The event COVID 19 occurred 2 months 22 days after the third dose of mRNA-1273 vaccine. Rechallenge is not applicable. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
Per 7 Jan 18 at 1120 medical record entry, patient presents for documentation of flu shot adverse event. States that on 2 Dec 2017 was given the flu vaccine in L deltoid. Around 9 Dec 17 noticed that left arm was sore and become increasingly more sore. Around 17 Dec 17 noticed a break in the skin where the vaccine was given that progressed to becoming wider, edematous, erythematous with scab formation. The area was raw, zero (0) drainage. Had had L shoulder pain since then. The scab resolved within a week. 29 Dec 17 made apt with Dr. who swabbed the scab and was given 1 gram of ROCEPHIN. 30 Dec 17 went to urgent care. Was seen by NP there. The NP believed that the vaccine hit a nerve. Was seen by (Ortho) 2 Jan 18 who believes that the flu shot was given in the nerve. Dr. sent to physical therapy. Reported 5 Jan 18. Went to 1st physical therapy visit was on 5 Jan 18. Physical therapist believes the median nerve was the affected nerve. Can't reach over head or behind her back. Physical therapist did "scraping" of the L deltoid.
Patient is not experinceing any adverse event.  she is 16 yrs and 2 months and received the moderna covid vaccine which is for 18 yrs and above
Immediately upon injection  I felt a sharp pain at the injection site. Immediately after my left arm began tingling all the way to my fingers. Within 20 minutes of vaccination my leg muscles were very week and the lower part of my legs began tingling  very strongly. It became difficult to even walk. My joints began  to hurt especially my wrists and and shoulders. I got body aches and felt extreme fatigue after about 2hrs. I felt feverish, however my temperature was within a normal range. After 1 week the fatigue was alleviated, but not completely. It has been 2weeks and I have not gained back my muscle strength, my joints still hurt, and my achilles tendon often feel(just a sensation) like it will snap when moving.
Receiver first dose on 3/4/2021, and second dose on 4/1/2021 both Moderna vaccines. By the first part of May 2021, I had reduction of vision and would easily attribute this to an adverse effect on the optic nerve, as an extrapolation of the neurological challenges and Inflammation causes by CoV2 infections in the brain and nervous system. Two different highly qualified Eye docs have not said affirmatively that my loss of  vision is vaccine induced, but neither have they disregarded the possibility. As a Medical Scientist myself, it is easy to put many interrogatories and adverse effects in the "We Just Don't Know"  column, since the virus is a novel, albeit a tinkered and undoubtedly engineered organism. Why in the world was the Gain of Function research not kept and studied in the US labs? Its genome was already known to enable producing the vaccine so fast is a given, and its adaptation to the RNA manufacturing techniques. Isn't this why the Administration waived all liability?
This spontaneous report as received from registered nurse refers to a 32 year old female patient. The patient had no pertinent medical history. On 28-NOV-2012 the patient was vaccinated with her first dose of VARIVAX (Merck) (lot number unknown) and on 02-JAN-2013 with her second dose. The patient used no concomitant medication. On 12-FEB-2013 a varicella/Zoster IgG titer was performed and the result was 0.81 Zoster IgG, where what was considered within normal limits from the lab after two doses would be 1.1 IgG or greater. No adverse effects reported. The outcome and relatedness of the event was not provided. Additional information has been requested.